» Articles » PMID: 32430359

Improved Molecular Detection of Mosaicism in Beckwith-Wiedemann Syndrome

Overview
Journal J Med Genet
Specialty Genetics
Date 2020 May 21
PMID 32430359
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Beckwith-Wiedemann Syndrome (BWS) is characterised by overgrowth and tumour predisposition. While multiple epigenetic and genetic mechanisms cause BWS, the majority are caused by methylation defects in imprinting control regions on chromosome 11p15.5. Disease-causing methylation defects are often mosaic within affected individuals. Phenotypic variability among individuals with chromosome 11p15.5 defects and tissue mosaicism led to the definition of the Beckwith-Wiedemann Spectrum (BWSp). Molecular diagnosis of BWSp requires use of multiple sensitive diagnostic techniques to reliably detect low-level aberrations.

Methods: Multimodal BWS diagnostic testing was performed on samples from 1057 individuals. Testing included use of a sensitive qRT-PCR-based quantitation method enabling identification of low-level mosaic disease, identification of CNVs within 11p15.5 via array comparative genomic hybridisation or qRT-PCR, and Sanger sequencing of .

Results: A molecular diagnosis was confirmed for 27.4% of individuals tested, of whom 43.4% had mosaic disease. The presence of a single cardinal feature was associated with a molecular diagnosis of BWSp in 20% of cases. Additionally, significant differences in the prevalence of mosaic disease among BWS molecular subtypes were identified. Finally, the diagnostic yield obtained by testing solid tissue samples from individuals with negative blood testing results shows improved molecular diagnosis.

Conclusion: This study highlights the prevalence of mosaic disease among individuals with BWSp and the increases in diagnostic yield obtained via testing both blood and solid tissue samples from affected individuals. Additionally, the results establish the presence of a molecular diagnosis in individuals with very subtle features of BWSp.

Citing Articles

Morphometric measurements of intraoral anatomy in children with Beckwith-Wiedemann syndrome: a novel approach.

Romeo D, George A, Sussman J, Banala M, Wiemken A, Wu M Orphanet J Rare Dis. 2024; 19(1):384.

PMID: 39420401 PMC: 11483972. DOI: 10.1186/s13023-024-03350-3.


Molecular mechanisms of human overgrowth and use of in its diagnostics: chances and challenges.

Prawitt D, Eggermann T Front Genet. 2024; 15:1382371.

PMID: 38894719 PMC: 11183334. DOI: 10.3389/fgene.2024.1382371.


Human embryonic genetic mosaicism and its effects on development and disease.

Waldvogel S, Posey J, Goodell M Nat Rev Genet. 2024; 25(10):698-714.

PMID: 38605218 PMC: 11408116. DOI: 10.1038/s41576-024-00715-z.


Choosing the Best Tissue and Technique to Detect Mosaicism in Fibrous Dysplasia/McCune-Albright Syndrome (FD/MAS).

Vado Y, Manero-Azua A, Pereda A, Perez de Nanclares G Genes (Basel). 2024; 15(1).

PMID: 38255009 PMC: 10815810. DOI: 10.3390/genes15010120.


Cancer predisposition signaling in Beckwith-Wiedemann Syndrome drives Wilms tumor development.

Nirgude S, Naveh N, Kavari S, Traxler E, Kalish J Br J Cancer. 2023; 130(4):638-650.

PMID: 38142265 PMC: 10876704. DOI: 10.1038/s41416-023-02538-x.


References
1.
Homig-Holzel C, Savola S . Multiplex ligation-dependent probe amplification (MLPA) in tumor diagnostics and prognostics. Diagn Mol Pathol. 2012; 21(4):189-206. DOI: 10.1097/PDM.0b013e3182595516. View

2.
Scott S, Cohen N, Brandt T, Toruner G, Desnick R, Edelmann L . Detection of low-level mosaicism and placental mosaicism by oligonucleotide array comparative genomic hybridization. Genet Med. 2010; 12(2):85-92. DOI: 10.1097/GIM.0b013e3181cc75d0. View

3.
Kalish J, Boodhansingh K, Bhatti T, Ganguly A, Conlin L, Becker S . Congenital hyperinsulinism in children with paternal 11p uniparental isodisomy and Beckwith-Wiedemann syndrome. J Med Genet. 2015; 53(1):53-61. PMC: 4740975. DOI: 10.1136/jmedgenet-2015-103394. View

4.
Brioude F, Kalish J, Mussa A, Foster A, Bliek J, Ferrero G . Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith-Wiedemann syndrome: an international consensus statement. Nat Rev Endocrinol. 2018; 14(4):229-249. PMC: 6022848. DOI: 10.1038/nrendo.2017.166. View

5.
Baskin B, Choufani S, Chen Y, Shuman C, Parkinson N, Lemyre E . High frequency of copy number variations (CNVs) in the chromosome 11p15 region in patients with Beckwith-Wiedemann syndrome. Hum Genet. 2013; 133(3):321-30. DOI: 10.1007/s00439-013-1379-z. View